Featured Image
April 12 – 2022

Commit Biologics attending the BioEquity, Milan 2022

Events

The BioInnovation Institute supports early-stage life science start-ups that contribute to improving human health for the benefit of people and society. But what are some of the most exciting BII portfolio companies in the biotech space right now? BioInnovation Institute asked their Portfolio Manager, Giles Dudley, and Business Developer, Matthias Wulf. They highlighted six companies including Commit Biologics.

Read more at BioInnovation Institute

Back to news

More news

Featured Image
August 28 – 2023

Commit Biologics appoints Krishna Polu as Chief Executive Officer

News
Krishna Polu is appointed CEO of Commit Biologics. Krishna brings a wealth of operating experience to the team with a track record of pipeline advancement and drug approvals across multiple therapeutics areas. Most recently, …
Featured Image
June 28 – 2023

Publication describing the BiCE technology featured in Journal of Immunology

Publication Research Technology
A joint collaboration between researchers from Commit Biologics, Christian-Albrechts-University in Kiel and Aarhus University has led to a better understanding of the complement system. The complement system plays a vital role in immune defenses. …
Featured Image
February 8 – 2023

Anker Lundemose is appointed chairman of the board

News
Commit welcomes Anker Lundemose as executive chairman of the board. MD, PhD Anker Lundemose is CEO at Mission Therapeutics (backed by Sofinnova Partners, Roche Venture Fund, Pfizer Ventures and SR One) and has held …

For inquiries please contact us
at info@commitbio.com

Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark

+45 3049 7099
LinkedIn

© 2022 Commit Biologics. All rights reserved.

CB_Brandmark_Light-Green